News
The Hon. J. Paul Oetken, United States District Court Judge for the Southern District of New York, entered an Order preliminarily approving a $1,600,000 class action settlement in Intellipharmaceutics Securities Litigation
Motion to dismiss this matter, which stems from alleged material misrepresentations and omissions made by defendants in describing the content and scope of studies included in the Rexista™ New Drug Application, was denied, in part, by the Hon. J. Paul Oetken, United States District Court Judge.